About Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1
La Fondazione IRCCS Istituto Nazionale dei Tumori, è un ospedale pubblico milanese dedicato esclusivamente alla cura del cancro, sia dal punto di vista clinico che da quello della ricerca.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1
During the past decade, Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1 conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on
average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1"
#1 collaborator was "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1
According to Clinical.Site data, the most researched conditions in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1" are
"Breast Cancer" (7 trials), "Colorectal Cancer" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Cancer" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1" in a lesser frequency.
Clinical Trials Intervention Types at Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1
Most popular intervention types in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1" are "Drug" (17 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (7 trials), "Pertuzumab" (5 trials), "Trastuzumab" (5 trials), "Trastuzumab Emtansine" (4 trials) and "Docetaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1
The vast majority of trials in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1" are
14 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1
Currently, there are NaN active trials in "Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1".
undefined are not yet recruiting,
4 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 1, 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".